Free radicals, antioxidant defense systems, and schizophrenia

Jing Qin Wu; Thomas R. Kosten; Xiang Yang Zhang

doi:10.1016/j.pnpbp.2013.02.015

journal article Oct 01, 2013

Free radicals, antioxidant defense systems, and schizophrenia

Jing Qin Wu Thomas R. Kosten Xiang Yang Zhang

Progress in Neuro-Psychopharmacology and Biological Psychiatry Vol. 46 pp. 200-206 · Elsevier BV

View at Publisher Save 10.1016/j.pnpbp.2013.02.015

Topics

No keywords indexed for this article. Browse by subject →

References

100

[1]

Abdalla "Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients" Clin Chem (1986) 10.1093/clinchem/32.5.805

[2]

Adler "Vitamin E treatment of tardive dyskinesia" Am J Psychiatry (1993) 10.1176/ajp.150.9.1405

[3]

Adler "Long-term treatment effects of vitamin E for tardive dyskinesia" Biol Psychiatry (1998) 10.1016/s0006-3223(97)00027-9

[4]

Akyol "Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia" Prog Neuropsychopharmacol Biol Psychiatry (2005) 10.1016/j.pnpbp.2004.10.014

[5]

Altuntas "Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients" Clin Chem Lab Med (2000) 10.1515/cclm.2000.201

[6]

Berg "Redox imbalance" Cell Tissue Res (2004) 10.1007/s00441-004-0976-5

[7]

Bernstein "The many faces of nitric oxide in schizophrenia" Schizophr Res (2005) 10.1016/j.schres.2005.05.019

[8]

Bitanihirwe "Oxidative stress in schizophrenia: an integrated approach" Neurosci Biobehav Rev (2011) 10.1016/j.neubiorev.2010.10.008

[9]

Buckman "Glutathione peroxidase and CT scan abnormalities in schizophrenia" Biol Psychiatry (1987) 10.1016/0006-3223(87)90069-2

[10]

Buckman "Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables" Psychiatry Res (1990) 10.1016/0165-1781(90)90103-c

[11]

Carpenter "The deficit syndrome" Am J Psychiatry (1994) 10.1176/ajp.151.3.327

[12]

Ciobica "Oxidative stress in schizophrenia — focusing on the main markers" Psychiatr Danub (2011)

[13]

Crow "Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors?" J Clin Psychopharmacol (1982) 10.1097/00004714-198210000-00010

[14]

Davies "Oxidative stress: the paradox of aerobic life" Biochem Soc Symp (1995) 10.1042/bss0610001

[15]

Dietrich-Muszalska "Isoprostenes as indicators of oxidative stress in schizophrenia" World J Biol Psychiatry (2009) 10.1080/15622970701361263

[16]

Do "Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo" Eur J Neurosci (2000) 10.1046/j.1460-9568.2000.00229.x

[17]

Egan "Treatment of tardive dyskinesia with vitamin E" Am J Psychiatry (1992) 10.1176/ajp.149.6.773

[18]

Gama "Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine" Prog Neuropsychopharmacol Biol Psychiatry (2006) 10.1016/j.pnpbp.2005.11.009

[19]

Gawryluk "Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders" Int J Neuropsychopharmacol (2011) 10.1017/s1461145710000805

[20]

Golse "Analysis of platelet superoxide dismutase 1 in the development of childhood psychoses" Nouv Presse Med (1977)

[21]

Griendling "Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology" Arterioscler Thromb Vasc Biol (2000) 10.1161/01.atv.20.10.2175

[22]

Halliwell "Phagocyte-derived reactive species: salvation or suicide?" Trends Biochem Sci (2006) 10.1016/j.tibs.2006.07.005

[23]

Halliwell "Biochemistry of oxidative stress" Biochem Soc Trans (2007) 10.1042/bst0351147

[24]

Harrison "Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence" Mol Psychiatry (2005) 10.1038/sj.mp.4001558

[25]

Herken "Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia" Mol Psychiatry (2001) 10.1038/sj.mp.4000789

[26]

Hitzeroth "Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population" Prog Neuropsychopharmacol Biol Psychiatry (2007) 10.1016/j.pnpbp.2006.12.019

[27]

Hoffer "Schizophrenia; a new approach. II. Result of a year's research" J Ment Sci (1954) 10.1192/bjp.100.418.29

[28]

Hori "Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia" Neuropsychopharmacology (2000) 10.1016/s0893-133x(99)00156-6

[29]

Horton "Lipid peroxidation and mechanisms of toxicity" Crit Rev Toxicol (1987) 10.3109/10408448709089856

[30]

Kang "Manganese superoxide dismutase gene Ala-9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients" Prog Neuropsychopharmacol Biol Psychiatry (2008) 10.1016/j.pnpbp.2008.08.013

[31]

Kohen "Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification" Toxicol Pathol (2002) 10.1080/01926230290166724

[32]

Konat "H2O2-induced higher order chromatin degradation: a novel mechanism of oxidative genotoxicity" J Biosci (2003) 10.1007/bf02970132

[33]

Kuloglu "Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder" Cell Biochem Funct (2002) 10.1002/cbf.940

[34]

Lau "Elevated neuronal nitric oxide synthase expression in chronic haloperidol-treated rats" Neuropharmacology (2003) 10.1016/s0028-3908(03)00314-9

[35]

Lee "Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls" Schizophr Res (2008) 10.1016/j.schres.2008.06.005

[36]

Li "Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia" Prog Neuropsychopharmacol Biol Psychiatry (2011) 10.1016/j.pnpbp.2011.03.001

[37]

Liu "Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients" Prog Neuropsychopharmacol Biol Psychiatry (2010) 10.1016/j.pnpbp.2010.03.026

[38]

Lockwood "Redox control of protein degradation" Antioxid Redox Signal (2000) 10.1089/ars.2000.2.4-851

[39]

Lohmueller "Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease" Nat Genet (2003) 10.1038/ng1071

[40]

Lohr "Oxygen radicals and neuropsychiatric illness. Some speculations" Arch Gen Psychiatry (1991) 10.1001/archpsyc.1991.01810360061009

[41]

Lohr "Free radical involvement in neuropsychiatric illnesses" Psychopharmacol Bull (1995)

[42]

Lohr "A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia" J Clin Psychiatry (1996)

[43]

Lohr "Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms" Schizophr Bull (1988) 10.1093/schbul/14.2.291

[44]

Lohr "Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia" Biol Psychiatry (1990) 10.1016/0006-3223(90)90490-s

[45]

Mahadik "Elevated plasma lipid peroxides at the onset of nonaffective psychosis" Biol Psychiatry (1998) 10.1016/s0006-3223(97)00282-5

[46]

Mahadik "Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia" Prog Neuropsychopharmacol Biol Psychiatry (2001) 10.1016/s0278-5846(00)00181-0

[47]

Matsuzawa "Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study" PLoS One (2008) 10.1371/journal.pone.0001944

[48]

McCreadie "The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects" Br J Psychiatry (1995) 10.1192/bjp.167.5.610

[49]

Mico "Reduced antioxidant defense in early onset first-episode psychosis: a case–control study" BMC Psychiatry (2011) 10.1186/1471-244x-11-26

[50]

Transition metals as catalysts of “autoxidation” reactions

D Miller

Free Radical Biology and Medicine 1990 10.1016/0891-5849(90)90148-c

Showing 50 of 100 references

Metrics

344

Citations

100

References

Details

Published: Oct 01, 2013
Vol/Issue: 46
Pages: 200-206
License: View

Authors

Funding

NHMRC

Department of Veterans Affairs, VISN 16, Mental Illness Research, Education and Clinical Center (MIRECC), United States National Institute of Health Award: K05-DA0454

Cite This Article

Jing Qin Wu, Thomas R. Kosten, Xiang Yang Zhang (2013). Free radicals, antioxidant defense systems, and schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 46, 200-206. https://doi.org/10.1016/j.pnpbp.2013.02.015

Free radicals, antioxidant defense systems, and schizophrenia

You May Also Like